A sensitive epitope-blocking ELISA for the detection of Chikungunya virus-specific antibodies in patients

Journal of Virological Methods

Volumn 222, Issue , 2015, Pages 55-61

  Goh, Lucas Y H ^a   Kam, Yiu Wing ^b   Metz, Stefan W ^c   Hobson Peters, Jody ^a   Prow, Natalie A ^a   McCarthy, Suzi ^d,e   Smith, David W ^d,e   Pijlman, Gorben P ^c   Ng, Lisa F P ^b   Hall, Roy A ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b AGENCY FOR SCIENCE   (Singapore)

^c WAGENINGEN UNIVERSITY   (Netherlands)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

Chikungunya virus; Clinical diagnostic; Epitope blocking ELISA; Monoclonal antibodies; Virus like particles

Indexed keywords

MONOCLONAL ANTIBODY; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS PROTEIN; EPITOPE; VIROSOME;

AEDES ALBOPICTUS; ANIMAL CELL; ANTIBODY DETECTION; ARTICLE; BARMAH FOREST VIRUS; CHIKUNGUNYA; CHIKUNGUNYA VIRUS; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CROSS REACTION; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE BLOCKING ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INSECT CELL; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROSS RIVER VIRUS; SENSITIVITY AND SPECIFICITY; VIRION; VIRUS CULTURE; VIRUS NEUTRALIZATION; VIRUS PARTICLE; BLOOD; CHIKUNGUNYA FEVER; EVALUATION STUDY; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; PROCEDURES;

ALPHAVIRUS; BARMAH FOREST VIRUS; CHIKUNGUNYA VIRUS; ROSS RIVER VIRUS;

ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CHIKUNGUNYA FEVER; CHIKUNGUNYA VIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; HUMANS; SENSITIVITY AND SPECIFICITY; VIROSOMES;

EID: 84930965987     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2015.05.011     Document Type: Article

References (58)

1. Adesina O.A., Odelola H.A. Ecological distribution of Chikungunya haemagglutination inhibition antibodies in human and domestic animals in Nigeria. Trop. Geogr. Med. 1991, 43(3):271-275.
2. Akahata W., Yang Z.Y., Andersen H., Sun S., Holdaway H.A., Kong W.P., Lewis M.G., Higgs S., Rossmann M.G., Rao S., Nabel G.J. A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection. Nat. Med. 2010, 16(3):334-338.
3. Angelini P., Macini P., Finarelli A.C., Pol C., Venturelli C., Bellini R., Dottori M. Chikungunya epidemic outbreak in Emilia-Romagna (Italy) during summer 2007. Parassitologia 2008, 50(1-2):97-98.
4. Baba M., Logue C.H., Oderinde B., Abdulmaleek H., Williams J., Lewis J., Laws T.R., Hewson R., Marcello A., D'Agaro P. Evidence of arbovirus co-infection in suspected febrile malaria and typhoid patients in Nigeria. J. Infect. Dev. Countr. 2013, 7(1):51-59.
5. Bessaud M., Peyrefitte C.N., Pastorino B.A., Tock F., Merle O., Colpart J.J., Dehecq J.S., Girod R., Jaffar-Bandjee M.C., Glass P.J., Parker M., Tolou H.J., Grandadam M. Chikungunya virus strains. Reunion Island outbreak. Emerg. Infect. Dis. 2006, 12(10):1604-1606.
6. Blacksell S.D., Tanganuchitcharnchai A., Jarman R.G., Gibbons R.V., Paris D.H., Bailey M.S., Day N.P., Premaratna R., Lalloo D.G., de Silva H.J. Poor diagnostic accuracy of commercial antibody-based assays for the diagnosis of acute Chikungunya infection. Clin. Vaccine Immunol. 2011, 18(10):1773-1775.
7. Blitvich B.J., Bowen R.A., Marlenee N.L., Hall R.A., Bunning M.L., Beaty B.J. Epitope-blocking enzyme-linked immunosorbent assays for detection of west nile virus antibodies in domestic mammals. J. Clin. Microbiol. 2003, 41(6):2676-2679.
8. Brandler S., Ruffie C., Combredet C., Brault J.B., Najburg V., Prevost M.C., Habel A., Tauber E., Despres P., Tangy F. A recombinant measles vaccine expressing Chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with Chikungunya virus. Vaccine 2013, 31(36):3718-3725.
9. Brighton S.W., Prozesky O.W., de la Harpe A.L. Chikungunya virus infection. A retrospective study of 107 cases. S. Afr. Med. J. 1983, 63(9):313-315.
10. Carey D.E. Chikungunya and dengue: a case of mistaken identity?. J. Hist. Med. Allied Sci. 1971, 26(3):243-262.
11. Chow A., Her Z., Ong E.K., Chen J.M., Dimatatac F., Kwek D.J., Barkham T., Yang H., Renia L., Leo Y.S., Ng L.F. Persistent arthralgia induced by Chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor. J. Infect. Dis. 2011, 203(2):149-157.
12. Clark D.C., Lobigs M., Lee E., Howard M.J., Clark K., Blitvich B.J., Hall R.A. In situ reactions of monoclonal antibodies with a viable mutant of Murray Valley encephalitis virus reveal an absence of dimeric NS1 protein. J. Gen. Virol. 2007, 88(4):1175-1183.
13. Economopoulou A., Dominguez M., Helynck B., Sissoko D., Wichmann O., Quenel P., Germonneau P., Quatresous I. Atypical Chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005-2006 outbreak on Reunion. Epidemiol. Infect. 2009, 137(4):534-541.
14. Edwards C.J., Welch S.R., Chamberlain J., Hewson R., Tolley H., Cane P.A., Lloyd G. Molecular diagnosis and analysis of Chikungunya virus. J. Clin. Virol. 2007, 39(4):271-275.
15. Gerardin P., Barau G., Michault A., Bintner M., Randrianaivo H., Choker G., Lenglet Y., Touret Y., Bouveret A., Grivard P., Roux K.L., Blanc S., Schuffenecker I., Couderc T., Arenzana-Seisdedos F., Lecuit M., Robillard P.Y. Multidisciplinary prospective study of mother-to-child Chikungunya virus infections on the island of La Reunion. PLoS Med. 2008, 5(3):e60.
16. Gibney K.B., Fischer M., Prince H.E., Kramer L.D., St George K., Kosoy O.L., Laven J.J., Staples J.E. Chikungunya fever in the United States: a fifteen year review of cases. Clin. Infect. Dis. 2011, 52(5):e121-e126.
17. Goh L.Y., Hobson-Peters J., Prow N.A., Gardner J., Bielefeldt-Ohmann H., Pyke A.T., Suhrbier A., Hall R.A. Neutralizing monoclonal antibodies to the E2 protein of Chikungunya virus protects against disease in a mouse model. Clin. Immunol. 2013, 149(3):487-497.
18. Grandadam M., Caro V., Plumet S., Thiberge J.M., Souares Y., Failloux A.B., Tolou H.J., Budelot M., Cosserat D., Leparc-Goffart I., Despres P. Chikungunya virus, southeastern France. Emerg. Infect. Dis. 2011, 17(5):910-913.
19. Hall R.A., Broom A.K., Hartnett A.C., Howard M.J., Mackenzie J.S. Immunodominant epitopes on the NS1 protein of MVE and KUN viruses serve as targets for a blocking ELISA to detect virus-specific antibodies in sentinel animal serum. J. Virol. Methods 1995, 51(2-3):201-210.
20. Hall R.A., Burgess G.W., Kay B.H. Type-specific monoclonal antibodies produced to proteins of Murray Valley encephalitis virus. Immunol. Cell Biol. 1988, 66(1):51-56.
21. Higgs S. Chikungunya virus: a major emerging threat. Vector Borne Zoonotic Dis. 2014, 14(8):535-536.
22. Hoarau J.J., Jaffar Bandjee M.C., Krejbich Trotot P., Das T., Li-Pat-Yuen G., Dassa B., Denizot M., Guichard E., Ribera A., Henni T., Tallet F., Moiton M.P., Gauzere B.A., Bruniquet S., Jaffar Bandjee Z., Morbidelli P., Martigny G., Jolivet M., Gay F., Grandadam M., Tolou H., Vieillard V., Debre P., Autran B., Gasque P. Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response. J. Immunol. 2010, 184(10):5914-5927.
23. Hopkins R., Esposito D. A rapid method for titrating baculovirus stocks using the Sf-9 Easy Titer cell line. Biotechniques 2009, 47(3):785-788.
24. Jaffar-Bandjee M.C., Ramful D., Gauzere B.A., Hoarau J.J., Krejbich-Trotot P., Robin S., Ribera A., Selambarom J., Gasque P. Emergence and clinical insights into the pathology of Chikungunya virus infection. Expert Rev. Anti-Infect. Ther. 2010, 8(9):987-996.
25. Knope K., Whelan P., Smith D., Johansen C., Moran R., Doggett S., Sly A., Hobby M., Wright P., Nicholson J., National A., Malaria Advisory C. Arboviral diseases and malaria in Australia, 2010-11: annual report of the National Arbovirus and Malaria Advisory Committee. Commun. Dis. Intell. Q. Rep. 2013, 37(1):E1-E20.
26. Kosasih H., Widjaja S., Surya E., Hadiwijaya S.H., Butarbutar D.P., Jaya U.A., Nurhayati, Alisjahbana B., Williams M. Evaluation of two IgM rapid immunochromatographic tests during circulation of Asian lineage Chikungunya virus. Southeast Asian J. Trop. Med. Public Health 2012, 43(1):55-61.
27. Kumar K.J., Manjunath V.G., Shailashree M., Girish G.N. Coinfection with dengue and Chikungunya-a case report. J. Indian Med. Assoc. 2012, 110(10):749, 752.
28. Lam S.K., Chua K.B., Hooi P.S., Rahimah M.A., Kumari S., Tharmaratnam M., Chuah S.K., Smith D.W., Sampson I.A. Chikungunya infection-an emerging disease in Malaysia. Southeast Asian J. Trop. Med. Public Health 2001, 32(3):447-451.
29. Lanciotti R.S., Valadere A.M. Transcontinental movement of Asian genotype Chikungunya virus. Emerg. Infect. Dis. 2014, 20(8):1400-1402.
30. Laurent P., Le Roux K., Grivard P., Bertil G., Naze F., Picard M., Staikowsky F., Barau G., Schuffenecker I., Michault A. Development of a sensitive real-time reverse transcriptase PCR assay with an internal control to detect and quantify Chikungunya virus. Clin. Chem. 2007, 53(8):1408-1414.
31. Lorono-Pino M.A., Farfan-Ale J.A., Blitvich B.J., Beebe J.L., Jarman R.G., Beaty B.J. Evaluation of an epitope-blocking enzyme-linked immunosorbent assay for the diagnosis of West Nile virus infections in humans. Clin. Vaccine Immunol. 2009, 16(5):749-755.
32. Mansuy J.M., Grouteau E., Mengelle C., Claudet I., Izopet J. Chikungunya in the Caribbean-threat for Europe. Emerg. Infect. Dis. 2014, 20(8):1423-1425.
33. Mavalankar D., Shastri P., Bandyopadhyay T., Parmar J., Ramani K.V. Increased mortality rate associated with Chikungunya epidemic, Ahmedabad, India. Emerg. Infect. Dis. 2008, 14(3):412-415.
34. Metz S.W., Gardner J., Geertsema C., Le T.T., Goh L., Vlak J.M., Suhrbier A., Pijlman G.P. Effective Chikungunya virus-like particle vaccine produced in insect cells. PLoS Negl. Trop. Dis. 2013, 7(3):e2124.
35. Metz S.W., Geertsema C., Martina B.E., Andrade P., Heldens J.G., van Oers M.M., Goldbach R.W., Vlak J.M., Pijlman G.P. Functional processing and secretion of Chikungunya virus E1 and E2 glycoproteins in insect cells. Virol. J. 2011, 8:353.
36. Niedrig M., Zeller H., Schuffenecker I., Drosten C., Emmerich P., Rumer L., Donoso-Mantke O. International diagnostic accuracy study for the serological detection of Chikungunya virus infection. Clin. Microbiol. Infect. 2009, 15(9):880-884.
37. Oliveira N.M., Broom A.K., Mackenzie J.S., Smith D.W., Lindsay M.D., Kay B.H., Hall R.A. Epitope-blocking enzyme-linked immunosorbent assay for detection of antibodies to Ross River virus in vertebrate sera. Clin. Vaccine Immunol. 2006, 13(7):814-817.
38. Powers A.M. Chikungunya virus control: is a vaccine on the horizon?. Lancet 2014.
39. Powers A.M., Logue C.H. Changing patterns of Chikungunya virus: re-emergence of a zoonotic arbovirus. J. Gen. Virol. 2007, 88(Pt 9):2363-2377.
40. Prabakaran M., Ho H.T., Prabhu N., Velumani S., Szyporta M., He F., Chan K.P., Chen L.M., Matsuoka Y., Donis R.O., Kwang J. Development of epitope-blocking ELISA for universal detection of antibodies to human H5N1 influenza viruses. PLoS ONE 2009, 4(2):e4566.
41. Rampal, Sharda M., Meena H. Neurological complications in Chikungunya fever. J. Assoc. Physicians IndiaV 55 2007, 765-769.
42. Reddy V., Ravi V., Desai A., Parida M., Powers A.M., Johnson B.W. Utility of IgM ELISA, TaqMan real-time PCR, reverse transcription PCR, and RT-LAMP assay for the diagnosis of Chikungunya fever. J. Med. Virol. 2012, 84(11):1771-1778.
43. Rezza G., Nicoletti L., Angelini R., Romi R., Finarelli A.C., Panning M., Cordioli P., Fortuna C., Boros S., Magurano F., Silvi G., Angelini P., Dottori M., Ciufolini M.G., Majori G.C., Cassone A. Infection with Chikungunya virus in Italy: an outbreak in a temperate region. Lancet 2007, 370(9602):1840-1846.
44. Rianthavorn P., Wuttirattanakowit N., Prianantathavorn K., Limpaphayom N., Theamboonlers A., Poovorawan Y. Evaluation of a rapid assay for detection of IgM antibodies to chikungunya. Southeast Asian J. Trop. Med. Public Health 2010, 41(1):92-96.
45. Robinson M.C. An epidemic of virus disease in Southern Province, Tanganyika territory, in 1952-1953. I. Clinical features. Trans. R. Soc. Trop. Med. Hyg. 1955, 49:28-32.
46. Roth A., Mercier A., Lepers C., Hoy D., Duituturaga S., Benyon E., Guillaumot L., Souares Y. Concurrent outbreaks of dengue, Chikungunya and Zika virus infections-an unprecedented epidemic wave of mosquito-borne viruses in the Pacific 2012-2014. Euro Surveill. 2014, 19(41.).
47. Sam I.C., Chua C.L., Chan Y.F. Chikungunya virus diagnosis in the developing world: a pressing need. Expert Rev. Anti-Infect. Ther. 2011, 9(12):1089-1091.
48. Santhosh S.R., Parida M.M., Dash P.K., Pateriya A., Pattnaik B., Pradhan H.K., Tripathi N.K., Ambuj S., Gupta N., Saxena P., Lakshmana Rao P.V. Development and evaluation of SYBR Green I-based one-step real-time RT-PCR assay for detection and quantification of Chikungunya virus. J. Clin. Virol. 2007, 39(3):188-193.
49. Schwartz O., Albert M.L. Biology and pathogenesis of Chikungunya virus. Nat. Rev. Microbiol. 2010, 8(7):491-500.
50. Sergon K., Yahaya A.A., Brown J., Bedja S.A., Mlindasse M., Agata N., Allaranger Y., Ball M.D., Powers A.M., Ofula V., Onyango C., Konongoi L.S., Sang R., Njenga M.K., Breiman R.F. Seroprevalence of Chikungunya virus infection on Grande Comore Island, union of the Comoros, 2005. Am. J. Trop. Med. Hyg. 2007, 76(6):1189-1193.
51. Sotelo E., Llorente F., Rebollo B., Camunas A., Venteo A., Gallardo C., Lubisi A., Rodriguez M.J., Sanz A.J., Figuerola J., Jimenez-Clavero M.A. Development and evaluation of a new epitope-blocking ELISA for universal detection of antibodies to West Nile virus. J. Virol. Methods 2011, 174(1-2):35-41.
52. Suhrbier A., Jaffar-Bandjee M.C., Gasque P. Arthritogenic alphaviruses-an overview. Nat. Rev. Rheumatol. 2012, 8(7):420-429.
53. Tandale B.V., Sathe P.S., Arankalle V.A., Wadia R.S., Kulkarni R., Shah S.V., Shah S.K., Sheth J.K., Sudeep A.B., Tripathy A.S., Mishra A.C. Systemic involvements and fatalities during Chikungunya epidemic in India, 2006. J. Clin. Virol. 2009, 46(2):145-149.
54. Tiwari M., Parida M., Santhosh S.R., Khan M., Dash P.K., Rao P.V. Assessment of immunogenic potential of Vero adapted formalin inactivated vaccine derived from novel ECSA genotype of Chikungunya virus. Vaccine 2009, 27(18):2513-2522.
55. Urdea M., Penny L.A., Olmsted S.S., Giovanni M.Y., Kaspar P., Shepherd A., Wilson P., Dahl C.A., Buchsbaum S., Moeller G., Hay Burgess D.C. Requirements for high impact diagnostics in the developing world. Nature 2006, 444(Suppl. 1):73-79.
56. Vazeille M., Mousson L., Martin E., Failloux A.B. Orally co-Infected Aedes albopictus from La Reunion Island, Indian Ocean, can deliver both dengue and Chikungunya infectious viral particles in their saliva. PLoS Negl. Trop. Dis. 2010, 4(6):e706.
57. Viennet E., Knope K., Faddy H.M., Williams C.R., Harley D. Assessing the threat of Chikungunya virus emergence in Australia. Commun. Dis. Intell. Q. Rep. 2013, 37(2):E136-E143.
58. Wang D., Suhrbier A., Penn-Nicholson A., Woraratanadharm J., Gardner J., Luo M., Le T.T., Anraku I., Sakalian M., Einfeld D., Dong J.Y. A complex adenovirus vaccine against Chikungunya virus provides complete protection against viraemia and arthritis. Vaccine 2011, 29(15):2803-2809.